Additionally, BPC-157 is investigated for its connection to circulation, collagen signaling, and pathways involved in tissue regeneration and recovery
Liraglutide (Saxenda/Victoza, Novo Nordisk) was the most common GLP-1 in the review and was included as the lone therapy in 16 studies and in combination with dulaglutide (Trulicity, Eli Lilly) in two studies
2024 Employer Health Benefits Survey
Final ICER judgments are nonbinding recommendations
At the five-year follow-up, the first-time biologic prescription was lower in the GLP-1 RA cohort versus the non-GLP-1 RA cohort (RR, 0.72)."As the prevalence of obesity continues to rise, it will be important to continue to evaluate how obesity may impact the management of CRS," the authors write